









Markets
/
Stocks
/
nasdaq-utmd
/

Utah Medical Products Inc

UTMD

62.773USD

+0.953+1.54%

Market hours （ET）Quotes delayed by 15 min

201.88MMarket Cap

16.08P/E TTM



Utah Medical Products Inc

62.773

+0.953+1.54%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

70 / 207

Overall Ranking

204 / 4723

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.

Growing

The company is in a growing phase, with the latest annual income totaling USD 40.90M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 30.19%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 30.19%.

Fairly Valued

The company’s latest PE is 16.49, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 2.53M shares, decreasing 21.68% quarter-over-quarter.

Held by Brandes Investmen

Star Investor Brandes Investmen holds 333.20K shares of this stock.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 9.46, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 9.95M, representing a year-over-year decrease of 4.30%, while its net profit experienced a year-over-year decrease of 11.73%.

Score

Industry at a Glance

Previous score

9.46

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.23

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.06

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 5.23, which is higher than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is 16.49, which is 16.57% below the recent high of 19.23 and 7.51% above the recent low of 15.25.

Score

Industry at a Glance

Previous score

6.01

Change

-0.78

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 70/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.70.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 8.49, which is higher than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 65.33 and the support level at 57.14, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.65

Change

-0.16

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.284

Neutral

RSI(14)

55.355

Neutral

STOCH(KDJ)(9,3,3)

43.100

Neutral

ATR(14)

1.431

High Vlolatility

CCI(14)

2.076

Neutral

Williams %R

63.708

Sell

TRIX(12,20)

0.348

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

62.332

Buy

MA10

62.474

Buy

MA20

61.501

Buy

MA50

58.644

Buy

MA100

56.785

Buy

MA200

58.178

Buy

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 77.79%, representing a quarter-over-quarter decrease of 0.37%. The largest institutional shareholder is Brandes Investmen, holding a total of 333.20K shares, representing 10.39% of shares outstanding, with 116.32% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Brandes Investment Partners, L.P.

Star Investors

242.25K

+48.65%

Renaissance Technologies LLC

Star Investors

217.71K

-1.71%

Dimensional Fund Advisors, L.P.

192.96K

+3.35%

Cornwell (Kevin L)

188.47K

The Vanguard Group, Inc.

Star Investors

176.37K

-0.45%

BlackRock Institutional Trust Company, N.A.

145.40K

-1.07%

Geode Capital Management, L.L.C.

107.78K

+10.05%

Hotchkis and Wiley Capital Management, LLC

Star Investors

101.64K

+35.20%

Minerva Advisors LLC

86.90K

+10.86%

State Street Global Advisors (US)

80.15K

-3.08%

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 5.69, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.33. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.